SINGAPORE, April 20, 2026 — Mindray officially inaugurated Mindray Singapore today and hosted a Strategic Partnership Signing Ceremony. The event was attended by Mindray leadership alongside distinguished experts and partners from the Economic Development Board (EDB), the National University of Singapore (NUS), and the Agency for Science, Technology and Research (A*STAR) to witness this milestone moment.
?scl=1)
During the ceremony, Mindray finalized strategic agreements with the National University of Singapore (NUS), the NUS (Guangzhou) Research Translation and Innovation Institute, and A*STAR. These partnerships are set to drive deep collaboration in cutting-edge medical fields, focusing on medical AI, advanced medical imaging, in-vitro diagnostics (IVD), surgical robotics, and cardiovascular disease treatment and diagnostics.
Guided by innovation and localization, Mindray is fostering a regional healthcare ecosystem through integrated collaboration. Mindray Singapore serves as a strategic hub to deepen R&D, cultivate talent, and enhance supply chain resilience alongside government, academic, and industry partners, bringing better healthcare for all.
The official launch of Mindray Singapore represents a critical step in Mindray’s global strategic layout. As Mindray embarks on this new journey of innovating with Singapore, the company will continue to uphold a philosophy of open collaboration, joining forces with top-tier global partners to explore the new frontiers of medical technology and contribute technological wisdom to the advancement of global health.